MWM
AVNS

Mascoma Wealth Management’s Avanos Medical AVNS Stock Holding History

Mascoma Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-62
Closed -$3K – 381
2019
Q1 		$3K Hold
62
– – ﹤0.01% 324
2018
Q4 		$3K Hold
62
– – ﹤0.01% 316
2018
Q3 		$4K Hold
62
– – ﹤0.01% 332
2018
Q2 		$4K Hold
62
– – ﹤0.01% 322
2018
Q1 		$3K Hold
62
– – ﹤0.01% 328
2017
Q4 		$3K Hold
62
– – ﹤0.01% 323
2017
Q3 		$3K Hold
62
– – ﹤0.01% 345
2017
Q2 		$2K Buy
+62
New +$2.34K ﹤0.01% 369

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mascoma Wealth Management's AVNS Position: Q2 2019 in Review

Mascoma Wealth Management sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 62 shares — an estimated $3K sold.

Mascoma Wealth Management first reported a position in AVNS in Q2 2017 and held it in 8 quarters. The position peaked at $4K in Q3 2018. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

  • Mascoma Wealth Management reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
  • Mascoma Wealth Management sold 62 Avanos Medical shares in Q2 2019, an estimated $3K.
  • Mascoma Wealth Management first reported a position in Avanos Medical in Q2 2017 and held it in 8 quarters.
  • Mascoma Wealth Management's Avanos Medical position peaked at $4K in Q3 2018.
  • 317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Mascoma Wealth Management's 13F filing for Q2 2019, filed 29 Jul 2019.